Healthcare

PRODUCTS

  • iMednet EDC
    Streamline Electronic Data Capture With iMednet EDC

    At the core of our comprehensive eClinical platform, iMednet EDC is uniquely designed to help sponsors and CROs achieve their clinical research goals. Highly flexible, it enables you to build studies quickly, while easily adapting to complex protocols and mid-study changes with ease.

  • Modern Medical Research Laboratory GettyImages-1293773048
    Highly Modular, Adaptive Digital Transformation Platform

    TrackWise Manufacturing makes it easier than ever for life sciences manufacturers of all sizes and complexities to achieve outstanding outcomes.

  • Equipment Manager 2
    Minimize Risk With Interactive Logbooks

    Guide operators through dynamic workflows from equipment startup to maintenance.

  • Laptop clinical trials iStock-653839742
    Pharmaceutical Change Control Software

    Using Document Change Control Software in Regulated Environments

    Change is important in any business, but it is especially critical in life science, manufacturing, and other regulated companies, which are required to "control" change as part of compliance. This is why many companies are turning to document change control software to help them address the complexity of change control.

    In regulated environments, the term "document change control" may refer to the document management or document control process, or it may to refer to the change control process, which involves rigorous documentation. Either way, most companies need document change control software to manage these processes.

  • GettyImages-1169924346 patient data collection
    Home Trial Support

    By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.

WHITE PAPERS AND CASE STUDIES

NEWS